In a major step toward advancing scientific research and strengthening international academic collaborations, the Presidency of the University of Garmian has successfully registered its official institutional Admin Account on the global platform ClinicalTrials.gov.

This milestone enables faculty members, medical professionals, and researchers at the university to officially register their clinical trial protocols, proposals, and biomedical research outcomes directly on this prestigious international database.

About ClinicalTrials.gov

Managed by the U.S. National Library of Medicine (NLM) and fully recognized by the World Health Organization (WHO), ClinicalTrials.gov is the world’s largest and most trusted registry for:

• Interventional Clinical Studies: Studies evaluating medical, surgical, or behavioral interventions.

• Observational Studies: Research focusing on biomedical or health outcomes in predefined patient groups.

Strategic Impact on High-Impact Publishing

Obtaining this institutional account addresses a critical academic requirement for modern biomedical publishing. Currently, the vast majority of top-tier international scientific journals (Q1 and Q2 rankings) mandate an official Registration Number from ClinicalTrials.gov as a prerequisite for reviewing, accepting, and publishing clinical and medical research.

By streamlining this verification process, the University of Garmian provides its researchers with a direct pathway to publishing in high-impact, peer-reviewed global journals according to strict international compliance standards.

Institutional Directory

To review the official registry of global academic and medical institutions holding certified accounts on this platform, you may click here.